{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:42:44Z","timestamp":1788525764276,"version":"build-2803163510"},"reference-count":145,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19XD1400300"],"award-info":[{"award-number":["19XD1400300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21430760800"],"award-info":[{"award-number":["21430760800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010843","name":"Guangzhou Science, Technology and Innovation Commission","doi-asserted-by":"publisher","award":["202201010743"],"award-info":[{"award-number":["202201010743"]}],"id":[{"id":"10.13039\/501100010843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.apsb.2022.10.020","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T22:35:24Z","timestamp":1667082924000},"page":"2544-2558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["The feasibility of oral targeted drug delivery: Gut immune to particulates?"],"prefix":"10.1016","volume":"13","author":[{"given":"Yuehong","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0164-0814","authenticated-orcid":false,"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2022.10.020_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2020.08.012","article-title":"Exploiting nanoscale cooperativity for precision medicine","volume":"158","author":"Wilhelm","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2022.10.020_bib2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.apsb.2019.08.003","article-title":"Recent progress in drug delivery","volume":"9","author":"Li","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.020_bib3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2022.10.020_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2018.12.028","article-title":"Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy","volume":"85","author":"Huang","year":"2019","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2022.10.020_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1369-7021(05)71033-6","article-title":"Targeted for drug delivery","volume":"8","author":"Fahmy","year":"2005","journal-title":"Mater Today"},{"key":"10.1016\/j.apsb.2022.10.020_bib6","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.2146\/news110084","article-title":"Targeted drug therapy remains a challenge","volume":"68","author":"Traynor","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.apsb.2022.10.020_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9798-5_1","article-title":"An overview of drug delivery systems","volume":"2059","author":"Jain","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.apsb.2022.10.020_bib8","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.2174\/13816128113199990698","article-title":"Physical and chemical stimuli-responsive drug delivery systems: targeted delivery and main routes of administration","volume":"19","author":"Lopes","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.apsb.2022.10.020_bib9","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1517\/17425247.2014.924500","article-title":"Orally active-targeted drug delivery systems for proteins and peptides","volume":"11","author":"Li","year":"2014","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.apsb.2022.10.020_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jocn.2021.01.037","article-title":"Long-term follow-up after BCNU wafer implantation in patients with newly diagnosed glioblastoma","volume":"86","author":"Shibahara","year":"2021","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.apsb.2022.10.020_bib11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1517\/17425247.2011.572068","article-title":"Stents as a platform for drug delivery","volume":"8","author":"Lei","year":"2011","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.apsb.2022.10.020_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/09687688.2010.510804","article-title":"Nanoparticulate drug delivery systems for cancer chemotherapy","volume":"27","author":"Saha","year":"2010","journal-title":"Mol Membr Biol"},{"key":"10.1016\/j.apsb.2022.10.020_bib13","first-page":"3879","article-title":"Brentuximab vedotin: first-line agent for advanced Hodgkin lymphoma","volume":"33","author":"Cao","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.apsb.2022.10.020_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15184","article-title":"Cemiplimab in advanced cutaneous squamous cell carcinoma","volume":"34","author":"Naik","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.apsb.2022.10.020_bib15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/17474124.2020.1807939","article-title":"The clinical application of camrelizumab on advanced hepatocellular carcinoma","volume":"14","author":"Chen","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2022.10.020_bib16","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2174\/1567201818666210609161301","article-title":"Targeted drug delivery: trends and perspectives","volume":"18","author":"Ashique","year":"2021","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.apsb.2022.10.020_bib17","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1016\/j.bmc.2017.06.040","article-title":"Nanoparticle-macrophage interactions: a balance between clearance and cell-specific targeting","volume":"25","author":"Rattan","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2022.10.020_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2012.12.009","article-title":"Injectable nanomaterials for drug delivery: carriers, targeting moieties, and therapeutics","volume":"84","author":"Webster","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2022.10.020_bib19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2022.10.020_bib20","article-title":"Current approaches of nanomedicines in the market and various stage of clinical translation","volume":"181","author":"Shan","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.020_bib21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jconrel.2020.04.006","article-title":"Overcoming the\u00a0intestinal\u00a0barrier: a look into targeting approaches for improved\u00a0oral drug delivery systems","volume":"322","author":"Xu","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2022.10.020_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.apsb.2018.10.005","article-title":"Emerging transporter-targeted nanoparticulate drug delivery systems","volume":"9","author":"Su","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.020_bib23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.apsb.2018.06.005","article-title":"Adapting liposomes for oral drug delivery","volume":"9","author":"He","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.020_bib24","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","article-title":"Progress and challenges towards targeted delivery of cancer therapeutics","volume":"9","author":"Rosenblum","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2022.10.020_bib25","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.apsb.2020.11.003","article-title":"Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: opportunities and emerging strategies","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.020_bib26","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.2174\/1381612825666190830155319","article-title":"Passive and active drug targeting: role of nanocarriers in rational design of anticancer formulations","volume":"25","author":"Das","year":"2019","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.apsb.2022.10.020_bib27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/pr.111.005363","article-title":"Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles","volume":"64","author":"Morachis","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apsb.2022.10.020_bib28","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.apsb.2021.03.019","article-title":"Metal-organic frameworks for advanced drug delivery","volume":"11","author":"He","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.020_bib29","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.drudis.2014.03.001","article-title":"Ligand-mediated active targeting for enhanced oral absorption","volume":"19","author":"Zhang","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2022.10.020_bib30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2147\/IJN.S237544","article-title":"Aptamers as versatile ligands for biomedical and pharmaceutical applications","volume":"15","author":"Guan","year":"2020","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2022.10.020_bib31","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1021\/acs.chemrev.7b00013","article-title":"Ligand-targeted drug delivery","volume":"117","author":"Srinivasarao","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2022.10.020_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120268","article-title":"Antibody-mediated drug delivery","volume":"596","author":"Arslan","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2022.10.020_bib33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1039\/C8BM01340C","article-title":"Peptide ligand-mediated targeted drug delivery of nanomedicines","volume":"7","author":"Jiang","year":"2019","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2022.10.020_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4155\/tde-2017-0013","article-title":"Biomimetic and bioinspired nanoparticles for targeted drug delivery","volume":"8","author":"Gagliardi","year":"2017","journal-title":"Ther Deliv"},{"key":"10.1016\/j.apsb.2022.10.020_bib35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.apsb.2020.09.016","article-title":"Recent advances in drug delivery systems for targeting cancer stem cells","volume":"11","author":"Duan","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.020_bib36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.apsb.2014.02.005","article-title":"Smart polymers for the controlled delivery of drugs\u2014a concise overview","volume":"4","author":"Priya James","year":"2014","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.020_bib37","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.apsb.2021.03.033","article-title":"Influencing factors and strategies of enhancing nanoparticles into tumors in\u00a0vivo","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.020_bib38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jconrel.2016.06.016","article-title":"Nanoparticles for oral delivery: design, evaluation and state-of-the-art","volume":"240","author":"Date","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2022.10.020_bib39","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cclet.2020.02.035","article-title":"The application of biomacromolecules to improve oral absorption by enhanced intestinal\u00a0permeability: a mini-review","volume":"31","author":"Sun","year":"2020","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2022.10.020_bib40","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1021\/mp300068j","article-title":"Delivery of peptides to the blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan nanoparticles","volume":"9","author":"Lalatsa","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2022.10.020_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/pharmaceutics11030129","article-title":"Challenges and recent progress in oral drug delivery systems for biopharmaceuticals","volume":"11","author":"Homayun","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2022.10.020_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nantod.2016.02.004","article-title":"Self-assembled peptide-based nanostructures: smart nanomaterials toward targeted drug delivery","volume":"11","author":"Habibi","year":"2016","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2022.10.020_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2022.10.020_bib44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2022.10.020_bib45","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.apsb.2021.02.020","article-title":"In\u00a0vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions","volume":"11","author":"Mart\u00ednez-L\u00f3pez","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.020_bib46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drudis.2007.10.023","article-title":"Discovery of tight junction modulators: significance for drug development and delivery","volume":"13","author":"Johnson","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2022.10.020_bib47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.addr.2020.07.026","article-title":"Application of advances in endocytosis and membrane trafficking to drug delivery","volume":"157","author":"Ju","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2022.10.020_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2006.01.003","article-title":"Tight junction modulation and its relationship to drug delivery","volume":"58","author":"Salama","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2022.10.020_bib49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nano.2011.09.014","article-title":"Cellular transport pathways of polymer coated gold nanoparticles","volume":"8","author":"Lin","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.apsb.2022.10.020_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202102519","article-title":"A Framework of paracellular transport via nanoparticles-induced endothelial leakiness","volume":"8","author":"Lee","year":"2021","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2022.10.020_bib51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1556-276X-8-66","article-title":"Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer","volume":"8","author":"Jiang","year":"2013","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.apsb.2022.10.020_bib52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/pharmaceutics11020078","article-title":"Intestinal permeation enhancers for oral delivery of macromolecules: a comparison between salcaprozate sodium (SNAC) and sodium caprate (C10)","volume":"11","author":"Twarog","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2022.10.020_bib53","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41565-020-0693-6","article-title":"Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions","volume":"15","author":"Han","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2022.10.020_bib54","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1021\/acsnano.5b03184","article-title":"Physical principles of nanoparticle cellular endocytosis","volume":"9","author":"Zhang","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2022.10.020_bib55","doi-asserted-by":"crossref","first-page":"13932","DOI":"10.1073\/pnas.212253499","article-title":"Transport of nitrated albumin across continuous vascular endothelium","volume":"99","author":"Predescu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2022.10.020_bib56","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1152\/physrev.1997.77.3.759","article-title":"Endocytosis","volume":"77","author":"Mukherjee","year":"1997","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2022.10.020_bib57","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.micinf.2005.04.003","article-title":"The role of enterocytes in the intestinal barrier function and antigen uptake","volume":"7","author":"Snoeck","year":"2005","journal-title":"Microb Infect"},{"key":"10.1016\/j.apsb.2022.10.020_bib58","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2018.0158","article-title":"The origins and evolution of macropinocytosis","volume":"374","author":"King","year":"2019","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.apsb.2022.10.020_bib59","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/icb.2011.20","article-title":"Macropinocytosis: an endocytic pathway for internalising large gulps","volume":"89","author":"Lim","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.apsb.2022.10.020_bib60","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1600-0854.2009.00878.x","article-title":"Defining macropinocytosis","volume":"10","author":"Kerr","year":"2009","journal-title":"Traffic"},{"key":"10.1016\/j.apsb.2022.10.020_bib61","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jconrel.2014.06.038","article-title":"Insight into nanoparticle cellular uptake and intracellular targeting","volume":"190","author":"Yameen","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2022.10.020_bib62","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1111\/febs.15078","article-title":"Transporter membrane traffic and function: lessons from a mould","volume":"286","author":"Diallinas","year":"2019","journal-title":"FEBS J"},{"key":"10.1016\/j.apsb.2022.10.020_bib63","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ncb3498","article-title":"Endocytic proteins are partitioned at the edge of the clathrin lattice in mammalian cells","volume":"19","author":"Sochacki","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2022.10.020_bib64","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1039\/c2cs15309b","article-title":"Endocytosis at the nanoscale","volume":"41","author":"Canton","year":"2012","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2022.10.020_bib65","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1146\/annurev-biochem-062917-012644","article-title":"Regulation of clathrin-mediated endocytosis","volume":"87","author":"Mettlen","year":"2018","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.apsb.2022.10.020_bib66","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrm.2017.132","article-title":"Mechanisms of clathrin-mediated endocytosis","volume":"19","author":"Kaksonen","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2022.10.020_bib67","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1039\/D1BM01154E","article-title":"Dual-sensitive dual-prodrug nanoparticles with light-controlled endo\/lysosomal escape for synergistic photoactivated chemotherapy","volume":"9","author":"Lu","year":"2021","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2022.10.020_bib68","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.ATV.0000070546.16946.3A","article-title":"Caveolin, caveolae, and endothelial cell function","volume":"23","author":"Frank","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.apsb.2022.10.020_bib69","first-page":"1141","article-title":"Preparation, characterization, and in\u00a0vitro and in\u00a0vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4","volume":"8","author":"Wang","year":"2013","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2022.10.020_bib70","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1166\/jbn.2018.2572","article-title":"Nanocochleates as the potential delivery systems for oral antitumor of hydroxycamptothecin","volume":"14","author":"Zhong","year":"2018","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.apsb.2022.10.020_bib71","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1023\/A:1026464526074","article-title":"Caveolae: an alternative membrane transport compartment","volume":"17","author":"Gumbleton","year":"2000","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.apsb.2022.10.020_bib72","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2174\/1389200220666190614150708","article-title":"Nanomedicine: bioavailability, biotransformation and biokinetics","volume":"20","author":"Ravindran","year":"2019","journal-title":"Curr Drug Metabol"},{"key":"10.1016\/j.apsb.2022.10.020_bib73","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2022.10.020_bib74","first-page":"1","article-title":"The endocytosis and intracellular fate of nanomedicines: implication for rational design","volume":"8","author":"Kou","year":"2013","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.apsb.2022.10.020_bib75","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1039\/D0CS01127D","article-title":"Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine","volume":"50","author":"Sousa de Almeida","year":"2021","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2022.10.020_bib76","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1083\/jcb.200407078","article-title":"Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles","volume":"168","author":"Kirkham","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2022.10.020_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmatsci.2019.100599","article-title":"Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy","volume":"107","author":"Guo","year":"2020","journal-title":"Prog Mater Sci"},{"key":"10.1016\/j.apsb.2022.10.020_bib78","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2022.10.020_bib79","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/physrev.00001.2003","article-title":"Transcytosis: crossing cellular barriers","volume":"83","author":"Tuma","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2022.10.020_bib80","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1021\/acs.molpharmaceut.8b00713","article-title":"Transport mechanisms of butyrate modified nanoparticles: insight into \u201ceasy entry, hard transcytosis\u201d of active targeting system in oral administration","volume":"15","author":"Wu","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2022.10.020_bib81","doi-asserted-by":"crossref","first-page":"11443","DOI":"10.1021\/acsami.7b19153","article-title":"Intestinal mucin induces more endocytosis but less transcytosis of nanoparticles across enterocytes by triggering nanoclustering and strengthening the retrograde pathway","volume":"10","author":"Yang","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2022.10.020_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120323","article-title":"Tailored elasticity combined with biomimetic surface promotes nanoparticle transcytosis to overcome mucosal epithelial barrier","volume":"262","author":"Zheng","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2022.10.020_bib83","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.apsb.2021.04.004","article-title":"Editorial of special issue \u201cthe biological fate of drug nanocarriers\u201d","volume":"11","author":"Wu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.020_bib84","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1007\/s12274-018-2152-3","article-title":"Strategies to improve micelle stability for drug delivery","volume":"11","author":"Lu","year":"2018","journal-title":"Nano Res"},{"key":"10.1016\/j.apsb.2022.10.020_bib85","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/1061186X.2014.950664","article-title":"Recent approaches of lipid-based delivery system for lymphatic targeting via oral route","volume":"22","author":"Chaudhary","year":"2014","journal-title":"J Drug Target"},{"key":"10.1016\/j.apsb.2022.10.020_bib86","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/1061186X.2020.1726356","article-title":"Cellular assays and applied\u00a0technologies for characterisation of orally administered protein nanoparticles: a systematic review","volume":"28","author":"Wong","year":"2020","journal-title":"J Drug Target"},{"key":"10.1016\/j.apsb.2022.10.020_bib87","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cclet.2020.09.038","article-title":"The intragastrointestinal fate of paclitaxel-loaded micelles: implications on oral drug delivery","volume":"32","author":"Zoya","year":"2021","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2022.10.020_bib88","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.addr.2015.08.001","article-title":"Stabilization challenges and formulation strategies associated with oral biologic drug delivery systems","volume":"93","author":"Truong-Le","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2022.10.020_bib89","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/sj.ijo.0802173","article-title":"When oral agents fail: practical barriers to starting insulin","volume":"26","author":"Korytkowski","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.apsb.2022.10.020_bib90","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4155\/TDE.15.47","article-title":"Why most oral insulin formulations do not reach clinical trials","volume":"6","author":"Lopes","year":"2015","journal-title":"Ther Deliv"},{"key":"10.1016\/j.apsb.2022.10.020_bib91","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2015.04.025","article-title":"Improving oral drug bioavailability with polycations?","volume":"97","author":"Schulz","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2022.10.020_bib92","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1021\/mp200572t","article-title":"Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations","volume":"9","author":"Sonaje","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2022.10.020_bib93","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.addr.2011.09.010","article-title":"Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery","volume":"64","author":"Sadekar","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2022.10.020_bib94","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/jps.21155","article-title":"Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system","volume":"97","author":"Ke","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.apsb.2022.10.020_bib95","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0005-2736(93)90159-W","article-title":"Polycation-induced enhancement of epithelial paracellular permeability is independent of tight junctional characteristics","volume":"1148","author":"McEwan","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2022.10.020_bib96","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejpb.2018.10.014","article-title":"The function and mechanism of preactivated thiomers in triggering epithelial tight junctions opening","volume":"133","author":"Zhang","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2022.10.020_bib97","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1021\/acsami.8b00507","article-title":"Novel solid lipid nanoparticle with endosomal escape function for oral delivery of insulin","volume":"10","author":"Xu","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2022.10.020_bib98","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1039\/C7NR06063G","article-title":"The combination of endolysosomal escape and basolateral stimulation to overcome the difficulties of \"easy uptake hard transcytosis\" of ligand-modified nanoparticles in oral drug delivery","volume":"10","author":"Cui","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2022.10.020_bib99","doi-asserted-by":"crossref","first-page":"34039","DOI":"10.1021\/acsami.8b13707","article-title":"Multifunctional nanoparticles enable efficient oral delivery of biomacromolecules via improving payload stability and regulating the transcytosis pathway","volume":"10","author":"Zheng","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2022.10.020_bib100","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/nano11030722","article-title":"Degradation mechanism of porous metal-organic frameworks by in situ atomic force microscopy","volume":"11","author":"Christodoulou","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.apsb.2022.10.020_bib101","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2174\/13892002113149990008","article-title":"Engineered inorganic nanoparticles for drug delivery applications","volume":"14","author":"Ojea-Jim\u00e9nez","year":"2013","journal-title":"Curr Drug Metabol"},{"key":"10.1016\/j.apsb.2022.10.020_bib102","doi-asserted-by":"crossref","first-page":"107518","DOI":"10.1016\/j.cclet.2022.05.032","article-title":"Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment","volume":"34","author":"Liu","year":"2023","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2022.10.020_bib103","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11095-007-9257-9","article-title":"Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin","volume":"24","author":"Bhumkar","year":"2007","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.apsb.2022.10.020_bib104","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.cclet.2021.08.113","article-title":"A \u201ccluster bomb\u201d oral drug delivery system to sequentially overcome the multiple absorption barriers","volume":"33","author":"Song","year":"2022","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2022.10.020_bib105","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s11095-015-1827-7","article-title":"Glucose-based mesoporous carbon nanospheres as functional carriers for oral delivery of amphiphobic raloxifene: insights into the bioavailability enhancement and lymphatic transport","volume":"33","author":"Ye","year":"2016","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.apsb.2022.10.020_bib106","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejpb.2015.04.023","article-title":"Phospholipid-stabilized mesoporous carbon nanospheres as versatile carriers for systemic delivery of amphiphobic SNX-2112 (a Hsp90 inhibitor) with enhanced antitumor effect","volume":"94","author":"Zhang","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2022.10.020_bib107","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.apsb.2020.12.022","article-title":"An update on oral drug delivery via intestinal lymphatic transport","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.020_bib108","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1574-695X.2007.00359.x","article-title":"M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis","volume":"52","author":"Corr","year":"2008","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.apsb.2022.10.020_bib109","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2018.02.021","article-title":"Exploiting or overcoming the dome trap for enhanced oral immunization and drug delivery","volume":"275","author":"Qi","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2022.10.020_bib110","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202100701","article-title":"A noninvasive gut-to-brain oral drug delivery system for treating brain tumors","volume":"33","author":"Miao","year":"2021","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2022.10.020_bib111","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2019.05.009","article-title":"Towards more accurate bioimaging of drug nanocarriers: turning aggregation-caused quenching into a useful tool","volume":"143","author":"Qi","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2022.10.020_bib112","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/molecules27010150","article-title":"Recent advances in aggregation-induced emission active materials for sensing of biologically important molecules and drug delivery system","volume":"27","author":"Zalmi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2022.10.020_bib113","doi-asserted-by":"crossref","first-page":"21660","DOI":"10.1021\/acsami.7b04916","article-title":"Size-dependent translocation of nanoemulsions via oral delivery","volume":"9","author":"Xia","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2022.10.020_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201800711","article-title":"Bioimaging of intact polycaprolactone nanoparticles using aggregation-caused quenching probes: size-dependent translocation via oral delivery","volume":"7","author":"He","year":"2018","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.apsb.2022.10.020_bib115","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ddtec.2005.05.019","article-title":"Nanoparticle uptake by the oral route: fulfilling its potential?","volume":"2","author":"Florence","year":"2005","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.apsb.2022.10.020_bib116","article-title":"In\u00a0vivo gastrointestinal drug-release monitoring through second near-infrared window fluorescent bioimaging with orally delivered microcarriers","volume":"8","author":"Wang","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2022.10.020_bib117","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s13346-015-0253-z","article-title":"Examining the gastrointestinal transit of lipid-based liquid crystalline systems\u00a0using whole-animal imaging","volume":"5","author":"Pham","year":"2015","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.apsb.2022.10.020_bib118","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.apsb.2021.03.006","article-title":"Gastrointestinal lipolysis and trans-epithelial transport of SMEDDS via oral route","volume":"11","author":"Xia","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2022.10.020_bib119","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.drudis.2016.09.024","article-title":"In\u00a0vivo fate of lipid-based nanoparticles","volume":"22","author":"Qi","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2022.10.020_bib120","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s11307-010-0456-0","article-title":"Molecular imaging techniques to study the biodistribution of orally administered 99mTc-labelled naive and ligand-tagged nanoparticles","volume":"13","author":"Areses","year":"2011","journal-title":"Mol Imag Biol"},{"key":"10.1016\/j.apsb.2022.10.020_bib121","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/10717544.2019.1710623","article-title":"OCTN2-targeted nanoparticles for oral delivery of paclitaxel: differential\u00a0impact of the polyethylene glycol linker size on drug\u00a0delivery in\u00a0vitro, in situ, and in\u00a0vivo","volume":"27","author":"Kou","year":"2020","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2022.10.020_bib122","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jconrel.2020.09.024","article-title":"The biological fate of orally administered mPEG-PDLLA polymeric micelles","volume":"327","author":"He","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2022.10.020_bib123","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/17435390.2011.552811","article-title":"Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration","volume":"6","author":"Schleh","year":"2012","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.apsb.2022.10.020_bib124","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2016.07.051","article-title":"Role of nanoparticle size, shape and surface chemistry in oral drug delivery","volume":"238","author":"Banerjee","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2022.10.020_bib125","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1039\/C5NR07474F","article-title":"Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery","volume":"8","author":"Hu","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2022.10.020_bib126","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.1021\/acsnano.8b04315","article-title":"Oral nanoparticles exhibit specific high-efficiency intestinal uptake and lymphatic transport","volume":"12","author":"Kim","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2022.10.020_bib127","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2147\/IJN.S125573","article-title":"Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects","volume":"12","author":"Song","year":"2017","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2022.10.020_bib128","doi-asserted-by":"crossref","first-page":"28110","DOI":"10.1039\/C5RA28018D","article-title":"Enhanced hepatic-targeted delivery via oral administration using nanoliposomes functionalized with a novel DSPE\u2013PEG\u2013cholic acid conjugate","volume":"6","author":"Li","year":"2016","journal-title":"RSC Adv"},{"key":"10.1016\/j.apsb.2022.10.020_bib129","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2147\/IJN.S125047","article-title":"Mechanism of hepatic targeting via oral administration of DSPE-PEG-cholic acid-modified nanoliposomes","volume":"12","author":"Li","year":"2017","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2022.10.020_bib130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/IJN.S187888","article-title":"Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency","volume":"14","author":"Li","year":"2019","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2022.10.020_bib131","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1021\/acs.molpharmaceut.1c00030","article-title":"Oral delivery of gambogenic acid by functional polydopamine nanoparticles for targeted tumor therapy","volume":"18","author":"Wang","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2022.10.020_bib132","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejpb.2015.10.010","article-title":"A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity","volume":"97","author":"Deng","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2022.10.020_bib133","doi-asserted-by":"crossref","first-page":"42186","DOI":"10.1021\/acsami.8b18979","article-title":"Hydrogen-bonded tannic acid-based anticancer nanoparticle for enhancement of oral chemotherapy","volume":"10","author":"Le","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2022.10.020_bib134","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1158\/1535-7163.MCT-08-0476","article-title":"In\u00a0vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities","volume":"7","author":"Bisht","year":"2008","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.apsb.2022.10.020_bib135","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1208\/s12249-018-1180-3","article-title":"Oral brain-targeted microemulsion for enhanced piperine delivery in Alzheimer's disease therapy: in\u00a0vitro appraisal, in\u00a0vivo activity, and nanotoxicity","volume":"19","author":"Etman","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.apsb.2022.10.020_bib136","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/10717544.2019.1689312","article-title":"Oral delivery of lycopene-loaded microemulsion for brain-targeting: preparation, characterization, pharmacokinetic evaluation and tissue distribution","volume":"26","author":"Guo","year":"2019","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2022.10.020_bib137","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1021\/acs.molpharmaceut.8b00357","article-title":"Entrapping of nanoparticles in yeast cell wall microparticles for macrophage-targeted oral delivery of cabazitaxel","volume":"15","author":"Ren","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2022.10.020_bib138","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.7150\/thno.35353","article-title":"Targeted delivery of cisplatin-derived nanoprecursors via a biomimetic yeast microcapsule for tumor therapy by the oral route","volume":"9","author":"Zhou","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2022.10.020_bib139","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1039\/D0BM00418A","article-title":"Biomimetic oral targeted delivery of bindarit for immunotherapy of atherosclerosis","volume":"8","author":"Yin","year":"2020","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2022.10.020_bib140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejpb.2022.02.004","article-title":"Is oral lipid-based delivery for drug targeting to the brain feasible?","volume":"172","author":"Brookes","year":"2022","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2022.10.020_bib141","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijbiomac.2020.03.148","article-title":"Advances and applications of chitosan-based nanomaterials as oral delivery carriers: a review","volume":"154","author":"Lang","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.apsb.2022.10.020_bib142","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s11095-010-0153-3","article-title":"Cellular entry of G3.5 poly (amido amine) dendrimers by clathrin- and dynamin-dependent endocytosis promotes tight junctional opening in intestinal epithelia","volume":"27","author":"Goldberg","year":"2010","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.apsb.2022.10.020_bib143","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal escape pathways for delivery of biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2022.10.020_bib144","doi-asserted-by":"crossref","first-page":"16489","DOI":"10.3390\/molecules191016489","article-title":"Modern prodrug design for targeted oral drug delivery","volume":"19","author":"Dahan","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2022.10.020_bib145","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1002\/med.21797","article-title":"Peroral targeting of drug micro or nanocarriers to sites beyond the gastrointestinal tract","volume":"41","author":"Zhang","year":"2021","journal-title":"Med Res Rev"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383522004452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383522004452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:00:34Z","timestamp":1761930034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383522004452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":145,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2211383522004452"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2022.10.020","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The feasibility of oral targeted drug delivery: Gut immune to particulates?","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2022.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}